These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Con: Impedance-pH testing does not commonly alter management of GERD. Richter JE Am J Gastroenterol; 2009 Nov; 104(11):2667-9. PubMed ID: 19888231 [No Abstract] [Full Text] [Related]
28. [Gastric and duodenal secretory and motor-evacuatory activity in patients with gastroesophageal reflux disease associated with different types of reflux]. Dzhulay GS; Sekareva EV Ter Arkh; 2016; 88(2):16-20. PubMed ID: 27030178 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829 [TBL] [Abstract][Full Text] [Related]
30. [Functional state of the gastro-duodenal area in gastro-esophageal reflux disease]. Vakhrushev IaM; Potapova LO Eksp Klin Gastroenterol; 2007; (3):22-6, 128. PubMed ID: 17937002 [TBL] [Abstract][Full Text] [Related]
31. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease. Dellon ES; Shaheen NJ Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864 [No Abstract] [Full Text] [Related]
33. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux]. Bredenoord AJ; Smout AJ Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935 [TBL] [Abstract][Full Text] [Related]
34. [Efficacy of the drinking magnesium-calcium sulfate mineral water in the combined treatment of duodenal ulcer comorbid with gastroesophageal reflux]. Vologzhanina LG; Vladimirskiĭ EV Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (6):17-9. PubMed ID: 16404920 [TBL] [Abstract][Full Text] [Related]
35. [Gastroesophageal reflux disease--diagnosis and management]. Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713 [TBL] [Abstract][Full Text] [Related]
36. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)]. Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061 [TBL] [Abstract][Full Text] [Related]
37. [Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction]. Maev IV; Samsonov AA; Ul'iankina EV; Nikushkina IN; Salova LM; Shakh IuS Eksp Klin Gastroenterol; 2007; (2):120-5. PubMed ID: 17539356 [No Abstract] [Full Text] [Related]
38. New developments in gastroesophageal reflux disease diagnosis and therapy. Ali T; Miner PB Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167 [TBL] [Abstract][Full Text] [Related]
39. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease]. Vasil'ev IuV; Beliaeva VS Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011 [No Abstract] [Full Text] [Related]
40. Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring. Cresi F; Marinaccio C; Russo MC; Miniero R; Silvestro L J Perinatol; 2008 Nov; 28(11):766-70. PubMed ID: 18580879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]